Back

ODYSSEY-HCM trial (mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy)

European Heart Journal - Cardiovascular Pharmacotherapy

14 October 2025
Organised by: Logo
Read full article
ESC Journals

Contributors

Emanuele Monda
Emanuele Monda

Author

Giuseppe Limongelli
Giuseppe Limongelli

Author

You may be interested in
thumbnail
Congress Presentation
The evolution of the obstructive HCM therapeutic landscape: emerging evidence about cardiac myosin inhibitors
31 August 2025
thumbnail
Congress Session
Ask the Trialists - ODYSSEY-HCM
30 August 2025
thumbnail
Congress Presentation
Mavacamten improves symptoms of shortness of breath in patients with obstructive hypertrophic cardiomyopathy (HCM): analysis of the HCM Symptom Questionnaire in the phase 3 EXPLORER trial
30 June 2021
thumbnail
Congress Presentation
Effects of mavacamten on left atrial function in hypertrophic obstructive cardiomyopathy
13 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources